Healthcare innovation consultancy Enspektos, LLC, today released the latest edition of its quarterly study, digihealth impact trac. The report focuses on key Q4 2017 market themes and previews five digital health trends that will matter in 2018. The research reveals that telemedicine is having a far-reaching impact as adoption surges globally. Most importantly, telemedicine solutions are delivering economic benefits and re-shaping the patient-physician relationship, as clinicians learn what it
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Why 2018 Will Be A Landmark Year for GE, Siemens, Canon and Philips
With the new year dawning, the competitive landscape for global medical technology is mired in uncertainty. Of the “big four” vendors (GE Healthcare, Siemens Healthineers, Philips and Toshiba Medical Systems) three are undergoing radical change, creating perhaps one of most volatile competitive market environments for some time. Add to this the visible presence of new market entrants from informatics, outsourcing, consumer technology and the rapidly growing artificial intelligence sector, and
Read More
Cota Partners with Miami Cancer Institute to Fuel Personalized Cancer Treatment
Cota, a healthcare data and analytics company bridging precision medicine to population health has announced their latest collaboration with Baptist Health South Florida to advance cancer treatment and clinical research at the new Miami Cancer Institute (MCI). The partnership will further support the organization’s initiative of precision medicine, improve care delivery and ensure the most effective treatment for every type of cancer.MCI will leverage Cota’s Provider Solution to identify
Read More
Precision Medicine Group Raises $275M to Support Biomarker-Guided Drug Development
Precision Medicine Group (PMG), an integrated team of experts focused on biomarker-guided drug development has raised $275 million in funding led by Berkshire Partners and TPG Growth and also includes significant participation from Precision’s co-founders and management team as well as original investors Oak Investment Partners and J.H. Whitney. . This investment will support the expansion of PMG’s global footprint and provide additional scale to accelerate the development, approval and
Read More
BioSymetrics Launches Analytics Platform to Revolutionize AI in Biomedicine
BioSymetrics, Inc., a technology company that aims to transform data analytics for the biomedical industry, today announced the launch of its pre-processing and analytics platform, Augusta. Augusta is a proprietary technology that allows standardized processing and integration of multiple, diverse raw data types, facilitating rapid deployment of AI projects in precision medicine, drug discovery, and digital health data applications. Currently, Augusta provides over 150 modules for the processing
Read More
Syapse Lands $30M to Expand Precision Oncology to More Healthcare Providers
Syapse, a a San Francisco, CA-based provider of precision oncology solutions, has raised $30 million in Series D financing. Participants include existing investors Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics, and Social Capital, as well as new investors Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund, and Roche Venture Fund.The company plans to use the latest round of funding to expand operations and bring its precision
Read More
Cleveland Clinic Selects PierianDx Platform to Accelerate Precision Medicine
Cleveland Clinic has selected PierianDx to utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patients. By joining the PierianDx customer network, Cleveland Clinic can now access the shared constitutional and somatic genomic data within CGW’s knowledge base, a robust database comprised of millions of biomedical findings driven by public and highly curated sources.PierianDx enables clinical labs to deliver
Read More
NIH Awards UCSF Researchers $11.7M Grant to Launch Pediatric Precision Medicine Equity Program
The National Institutes of Health (NIH) has awarded a team of UC San Francisco researchers with a four-year $11.7 million grant to launch a new Prenatal and Pediatric Genomic Sequencing (P3EGS ) program at UCSF, according to UCSF news. Over the four-year span, the program is focused on pursuing equity in the implementation of genomic precision medicine for children and families in the San Francisco Bay Area.As part of the pediatric precision medicine program, the P3EGS team will recruit 1,100
Read More
Cara Raises $2M for First Precision Medicine App for Digestive Health
Cara, a Berlin-based digital health startup has raised $2 million in seed funding led by Atlantic Labs along with a group of undisclosed angel investors. Known as “poop-tech”, the company has launched the first precision medicine solution for digestive health. In 2016, HiDoc Technologies launched the Cara app with the aim to help people with chronic digestive disorders. Today, more than 20% of the world’s population suffer from the Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease
Read More
University of Chicago Medicine, Tempus Partner on Personalized Pancreatic Cancer Project
Pancreatic cancer is the third leading cause of cancer-related death in the United States. It has a five-year survival rate of just nine percent. Lack of effective treatments and early detection methods contribute to this grim prognosis. Personalized approaches to match a patient’s genomic information to therapies have led to improvements in treatment of other cancer types. None of the genetic mutations commonly seen in pancreatic cancer, however, have “druggable” targets.That’s why the
Read More
